Bharat Biotech Gets DGCI Nod To Take COVAXIN To Phase II Human Clinical Trials

Like
Like Love Haha Wow Sad Angry

COVAXIN Enters Phase-II Trials As Bharat Biotech Received DCGI Nod COVAXIN vaccine, India’s indigenous Covid-19 vaccine by Bharat Biotech enters Phase II human clinical trials after receiving approval from the Drugs Controller General of India. In order to conduct Phase II human clinical trials of Bharat Biotech’s indigenously developed Covaxin, Bharat Biotech received a nod […]

The post Bharat Biotech Gets DGCI Nod To Take COVAXIN To Phase II Human Clinical Trials appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/09/covaxin-enters-phase-ii-trials-as-bharat-biotech-received-dcgi-nod/

Like
Like Love Haha Wow Sad Angry